Petros Pharmaceuticals, Inc. (PTPI) earnings

PTPI earnings moved a median of -4.58% by the close. Quarterly and annual PTPI reports and results, each read against the price at its own news timestamp. Back to the PTPI overview →

14 measured PTPI earnings events.

Where these PTPI earnings landedvs 14 measured PTPI earnings reactions
PTPI earningsMiddle 50% · -9.08% to -0.81%Zero: 0.00%Median: -4.58%Median -4.58%-15.00%0+15.00%
Middle 50% of PTPI earnings reactions-9.08% to -0.81%
Median reaction (to close)-4.58%
Measured reactions14
Point-in-time · zero look-ahead

Half of the 14 PTPI earnings events with a measured close landed between -9.08% and -0.81%; 21% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Petros Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q+0.00%-10.00%
Form 10-Q Petros Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q-11.11%-5.56%
Form 10-K Petros Pharmaceuticals, For: Dec 31SEC filing · Form 10-K+0.00%+13.33%
Form NT 10-K Petros Pharmaceuticals, For: Dec 31SEC filing · Form NT-1.72%-6.32%
Form 10-Q Petros Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q+0.00%-1.29%
Form 10-Q Petros Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q-9.87%-11.27%
Form 10-K Petros Pharmaceuticals, For: Dec 31SEC filing · Form 10-K+2.58%+35.48%
Form 10-Q Petros Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q+1.21%-3.46%
Form 10-Q Petros Pharmaceuticals, For: Jun 30SEC filing · Form 10-Q+0.00%-0.65%
Form 10-K/A Petros Pharmaceuticals, For: Dec 31SEC filing · Form 10-K-0.60%-20.15%
Form 10-Q Petros Pharmaceuticals, For: Mar 31SEC filing · Form 10-Q+3.98%+0.02%
Form 10-K Petros Pharmaceuticals, For: Dec 31SEC filing · Form 10-K-7.45%-11.57%
Form 10-Q Petros Pharmaceuticals, For: Sep 30SEC filing · Form 10-Q+2.29%-4.58%
Form NT 10-Q Petros Pharmaceuticals, For: Sep 30SEC filing · Form NT+2.29%-4.58%
That’s how PTPI usually reacts to earnings — get an email when it moves on news →
Keep exploring

More PTPI: analyst actions → · SEC filings → · PTPI overview →